Page last updated: 2024-11-01

nifedipine and Adenomatous Polyposis Coli

nifedipine has been researched along with Adenomatous Polyposis Coli in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.

Research Excerpts

ExcerptRelevanceReference
"We report a patient with hereditary non-polyposis coli and metastatic colon cancer who had a complete response after treatment with a high dose of nifedipine, a calcium channel blocker."1.31Effect of nifedipine in metastatic colon cancer with DNA mismatch repair gene defect. ( Friedlander, ML; Yang, JL, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, JL1
Friedlander, ML1

Other Studies

1 other study available for nifedipine and Adenomatous Polyposis Coli

ArticleYear
Effect of nifedipine in metastatic colon cancer with DNA mismatch repair gene defect.
    Lancet (London, England), 2001, Jun-02, Volume: 357, Issue:9270

    Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Calcium Channel Blockers; Colonic Neoplasms; DNA Repair;

2001